Clinical Trial: Treatment Patterns and Outcomes in Patients With Lower-risk Myelodysplastic Syndromes Treated With Luspatercept in China

U.S., July 19 -- ClinicalTrials.gov registry received information related to the study (NCT07073690) titled 'Treatment Patterns and Outcomes in Patients With Lower-risk Myelodysplastic Syndromes Treated With Luspatercept in China' on July 10.

Brief Summary: The purpose of this study is to evaluate the treatment patterns and clinical outcomes in adults with lower-risk MDS (LR-MDS) who were erythropoiesis-stimulating agents (ESA)-naive and received luspatercept treatment in China

Study Start Date: April 18

Study Type: OBSERVATIONAL

Condition: Myelodysplastic Syndromes

Intervention: DRUG: Luspatercept

According to the product label

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Bristol-Myers Squibb

Disclaimer: Curated by HT Synd...